Latest News

• share
• favorite_border

A new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to reduce colorectal cancer screening disparities in Black communities. According to the qualitative study published in the Journal of Cancer Education, people in Kentucky’s Black communities may not be aware about all of the colorectal cancer screening options available to them, particularly stool-based tests.

• share
• favorite_border

The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of lecanemab (investigational antibody) in people who have no cognitive symptoms of Alzheimer’s disease (AD), but in whom biomarker tests indicate amyloid is present in the brain, known as “preclinical” AD.

• share
• favorite_border

Nearly every person in the United States has been exposed to per- and polyfluorinated alkyl substances (PFAS) at some point in their life. These “forever chemicals” are the focus of a targeted investigation by University of Kentucky Superfund Research Center (UKSRC) researchers who are working collaboratively with community partners to protect Kentuckians.

• share
• favorite_border

The University of Kentucky Markey Cancer Center has received renewed funding from the American Cancer Society to support a long-standing faculty research program. The ACS’ Institutional Research Grant is intended to help junior faculty establish and advance cancer research programs.

• share
• favorite_border

The goal of the project is to create a membrane-based downstream purification platform for large-scale continuous biomanufacturing of viral vectors and virus-like particles (VLPs).

• share
• favorite_border

Donna Wilcock, Ph.D., of the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs — aducanumab and lecanemab —​ which have been shown to slow the progression of cognitive decline.

• share
• favorite_border

As a stand-up comedian, Debra Faulk is an expert at transforming the most difficult and uncomfortable moments of her life into something that lifts others. Active in the local comedy scene, the 54-year-old Lexington native uses standup as a platform to shine a light on serious health issues, with much of her routine inspired by her family’s experiences: one sister dealt with intellectual disabilities while another had breast cancer, her brother served in Desert Storm and came back with PTSD, her father had dementia, and her mother was on dialysis.

• share
• favorite_border

The University of Kentucky Markey Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer (NAPRC).

• share
• favorite_border

A University of Kentucky Markey Cancer Center researcher’s team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors. The study led by Samuel G. Awuah, Ph.D., was published in Chemical Communications with Adedamola Arojojoye, a graduate student in Awuah’s lab as the paper’s first author.

• share
• favorite_border

A new book by Peter Kalliney, William J. and Nina B. Tuggle chair in English in the University of Kentucky's College of Arts & Sciences, looks at ways in which rival superpowers used cultural diplomacy and the political police to influence writers.

• share
• favorite_border

The University of Kentucky Markey Cancer Center received a grant through the Alliance for Equity in Cancer Care, an initiative funded by the Merck Foundation. The Alliance is designed to make cancer care more equitable in the U.S. by helping patients who live in underserved communities receive timely access to high-quality, culturally responsive care.

• share
• favorite_border

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.Since its inception in 2005, Alzheimer’s & Dementia has sought to bridge the knowledge gaps that separate traditional fields of dementia research by rapidly disseminating new findings and acting as a forum for articles covering clinical investigations and basic, social and behavioral research.

• share
• favorite_border

A team of researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) has been awarded a $20.5 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH). The P01 award exemplifies team science, helping to support about 35 researchers across six different labs who will be working on four main projects, all with a common theme.

• share
• favorite_border

A study led by the University of Kentucky has been selected for funding by the National Science Foundation’s (NSF) “Biodiversity on a Changing Planet” program, an international, transdisciplinary effort that addresses major challenges related to climate change. The five-year project has been awarded nearly $2.5 million.

• share
• favorite_border

For her most recent project, “Mechanical Mechanisms of Biofilm Survival on Implant Surfaces,” Dr. Martha Grady, an associate professor in the Department of Mechanical and Aerospace Engineering at the University of Kentucky, is the recipient of the National Science Foundation's (NSF) prestigious Faculty Early Career Development (CAREER) Award.

• share
• favorite_border

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease. A four-year grant from the National Institute on Aging of the National Institutes of Health to Northwestern University includes a $611,676 subaward to UK. Van Eldik, the Dr. E. Vernon Smith and Eloise C. Smith Alzheimer's Research Endowed Chair, serves as principal investigator on UK’s award.

• share
• favorite_border

A new study published by University of Kentucky Markey Cancer Center researchers suggests that the common steroid betamethasone could be used to reduce unwanted side effects of radiation treatments for prostate cancer.

• share
• favorite_border

On Aug. 23, Kentucky Children’s Hospital (KCH) will celebrate its 25th anniversary of serving the children of the Commonwealth. The hospital has grown since 1997, in both physical capacity and in the types of specialty care for every child, from infant to young adults.

• share
• favorite_border

The Commonwealth of Kentucky is dealing with a second catastrophic weather event in just a matter of months. Back in December, areas of Western Kentucky were decimated by some of the strongest tornadoes to hit the state in recent memory. This time, Eastern Kentucky has been hit with devastation, with the damage and casualties from these historic floods spanning across multiple counties. The pictures coming out of the impacted areas have overwhelmed the entire state with grief for their neighbors who will feel the effects of this tragedy for months and years to come.

• share
• favorite_border

Today (July 25), UK HealthCare and community leaders celebrated the full opening of the Sanders-Brown Memory Clinic at Turfland. The new, larger clinic replaces the former Sanders-Brown facilities along North Broadway in Lexington. The world looks to The University of Kentucky’s Sanders-Brown Center on Aging for answers to the mysteries of dementia, and the elderly rely on them for help in charting their path to a healthy and vigorous senior lifestyle. After outgrowing their old space, leaders at UK decided it was time that Sanders-Brown’s home for clinical research and patient care reflects their reputation — building them a new home on UK HealthCare’s Turfland Campus.